Civica to Build an Essential Medicines Manufacturing Facility in Virginia

The new facility, part of a partnership with Virginia-based Phlow Corp., will employ more than 180 people and will help ensure a safe, stable, and affordable supply of essential generic medicines for U.S. patients. Civica will produce sterile injectable medications used in hospitals for COVID-19 patient care, emergency room and intensive-care unit treatments, surgeries,...

Sandoz Collaborates with Civica Rx to Help Reduce Critical Generic Medicine Shortages in US Hospitals

Sandoz Inc. today announced it has entered into a long-term agreement with Civica Rx (Civica, Inc.) to manufacture and supply critical injectable generic medicines, to help reduce supply shortages and ensure acute care settings can deliver optimal patient care. Under the five-year agreement, Sandoz will supply six injectable medicines widely used at Civica’s 1,200...

Kaiser Permanente Joins Forces with Civica Rx to Improve Availability and Affordability of Essential Generic Medication

Kaiser Permanente, the nation’s largest nonprofit, integrated health system, announced that it is joining with nonprofit Civica Rx in its mission of assuring that health providers nationally have access to stable and affordable supplies of essential generic medications throughout the COVID-19 pandemic and beyond. Kaiser Permanente joins Civica as a governing member with a...

Civica Update: Civica Rx Partners on COVID-19 Response and “End-to-End” U.S. Based Generic Drug Manufacturing

  Civica Rx  is part of a new U.S. Government-funded partnership that was announced today to produce essential generic medicines and their ingredients at one location in the United States. Teams within the Department of Health and Human Services (HHS) are working with a team of private industry partners to expand generic pharmaceutical manufacturing...

Scroll to top